Incidental Mutation 'R8504:H2-DMa'
ID 655499
Institutional Source Beutler Lab
Gene Symbol H2-DMa
Ensembl Gene ENSMUSG00000037649
Gene Name histocompatibility 2, class II, locus DMa
Synonyms H-2Ma, H2-Ma, H2-M alpha
MMRRC Submission 067840-MU
Accession Numbers
Essential gene? Probably non essential (E-score: 0.236) question?
Stock # R8504 (G1)
Quality Score 225.009
Status Not validated
Chromosome 17
Chromosomal Location 34338667-34358075 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 34357416 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Asparagine to Aspartic acid at position 230 (N230D)
Ref Sequence ENSEMBL: ENSMUSP00000037088 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000042121]
AlphaFold no structure available at present
Predicted Effect probably damaging
Transcript: ENSMUST00000042121
AA Change: N230D

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000037088
Gene: ENSMUSG00000037649
AA Change: N230D

DomainStartEndE-ValueType
signal peptide 1 26 N/A INTRINSIC
MHC_II_alpha 42 123 2.83e-19 SMART
IGc1 142 212 5.82e-23 SMART
transmembrane domain 231 253 N/A INTRINSIC
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 100.0%
  • 10x: 99.7%
  • 20x: 99.1%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] HLA-DMA belongs to the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DMA) and a beta chain (DMB), both anchored in the membrane. It is located in intracellular vesicles. DM plays a central role in the peptide loading of MHC class II molecules by helping to release the CLIP molecule from the peptide binding site. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and the cytoplasmic tail. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygotes for targeted null mutations exhibit impaired antigen presenting cell function, poor IgG responses to T-dependent antigens, reduced numbers of mature CD4+ T cells, and increased susceptibility to Leishmania major infection. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 67 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Abca4 T C 3: 121,922,983 (GRCm39) S1181P probably benign Het
Acvr1c C T 2: 58,173,491 (GRCm39) C337Y probably damaging Het
Adgrf5 A G 17: 43,757,840 (GRCm39) E758G probably benign Het
Akap3 T A 6: 126,841,493 (GRCm39) D37E probably damaging Het
Ano5 A T 7: 51,222,776 (GRCm39) H445L probably benign Het
Ap4b1 T A 3: 103,720,116 (GRCm39) I121N probably damaging Het
Arhgdia T C 11: 120,470,354 (GRCm39) K135E probably benign Het
Ass1 T C 2: 31,391,544 (GRCm39) F273S possibly damaging Het
Atp8a2 A C 14: 59,885,366 (GRCm39) Y1119* probably null Het
Birc6 T A 17: 74,959,000 (GRCm39) M3839K probably damaging Het
Cacna1a A G 8: 85,365,370 (GRCm39) H2171R probably benign Het
Ccdc90b T A 7: 92,224,545 (GRCm39) D183E probably benign Het
Ccng2 C G 5: 93,421,202 (GRCm39) S237R probably benign Het
Cdh23 T A 10: 60,274,618 (GRCm39) T491S probably benign Het
Cercam T C 2: 29,771,829 (GRCm39) S550P possibly damaging Het
Chd9 A G 8: 91,723,472 (GRCm39) H1019R unknown Het
Coil A T 11: 88,871,980 (GRCm39) K114* probably null Het
Csmd2 A C 4: 128,440,483 (GRCm39) T3183P Het
Cul9 T C 17: 46,814,506 (GRCm39) Y2219C probably damaging Het
Efhd2 G A 4: 141,587,186 (GRCm39) Q199* probably null Het
Elp3 A T 14: 65,785,360 (GRCm39) S499R probably benign Het
Exoc8 T G 8: 125,622,709 (GRCm39) I553L probably benign Het
Fyco1 C A 9: 123,659,142 (GRCm39) V345L probably benign Het
Galr3 T A 15: 78,927,279 (GRCm39) V240E probably damaging Het
Gm21190 A G 5: 15,730,862 (GRCm39) S165P probably benign Het
Gnal T A 18: 67,350,255 (GRCm39) Y372* probably null Het
Hk2 T C 6: 82,721,847 (GRCm39) D164G possibly damaging Het
Ighv3-4 T A 12: 114,217,544 (GRCm39) I16F possibly damaging Het
Ivl T C 3: 92,480,078 (GRCm39) probably benign Het
Klhl8 G A 5: 104,015,814 (GRCm39) T434M probably benign Het
Lct A T 1: 128,215,306 (GRCm39) S1757T probably damaging Het
Lmbr1l T A 15: 98,810,065 (GRCm39) Y132F probably damaging Het
M6pr T C 6: 122,293,029 (GRCm39) V203A possibly damaging Het
Map9 T C 3: 82,284,476 (GRCm39) probably null Het
Muc5ac A T 7: 141,360,892 (GRCm39) D1401V probably damaging Het
Myh7 A G 14: 55,227,786 (GRCm39) S291P probably damaging Het
Nynrin G C 14: 56,107,703 (GRCm39) V937L probably benign Het
Or5d44 C T 2: 88,141,825 (GRCm39) G105D probably benign Het
Or5m3 T G 2: 85,838,149 (GRCm39) F10V probably damaging Het
Pank2 A G 2: 131,135,320 (GRCm39) N386S probably benign Het
Phkg2 G T 7: 127,181,528 (GRCm39) R237L possibly damaging Het
Pkhd1 C T 1: 20,590,432 (GRCm39) V1772I probably benign Het
Plch2 G T 4: 155,068,852 (GRCm39) P1258Q probably benign Het
Plekhm2 A T 4: 141,369,764 (GRCm39) I77N probably damaging Het
Ptprb A G 10: 116,176,936 (GRCm39) T954A probably benign Het
Ranbp3 T C 17: 57,015,273 (GRCm39) V325A probably damaging Het
Rgs10 A T 7: 128,019,793 (GRCm39) S16T probably benign Het
Scaper A T 9: 55,771,722 (GRCm39) V398E probably benign Het
Selenot A G 3: 58,492,698 (GRCm39) I62V probably benign Het
Serpinb9e T A 13: 33,439,092 (GRCm39) C173S probably benign Het
Slc13a3 G T 2: 165,275,999 (GRCm39) T249K probably damaging Het
Slc4a8 T A 15: 100,701,171 (GRCm39) V741D possibly damaging Het
Slco4a1 T C 2: 180,106,592 (GRCm39) V258A probably damaging Het
Sycp2l T G 13: 41,291,390 (GRCm39) L256R probably damaging Het
Tektl1 T C 10: 78,585,038 (GRCm39) D266G probably benign Het
Tektl1 T C 10: 78,586,463 (GRCm39) D196G probably damaging Het
Top2a C T 11: 98,905,567 (GRCm39) V337I probably benign Het
Tut4 T C 4: 108,388,139 (GRCm39) L1160P probably damaging Het
Unc13a A C 8: 72,098,405 (GRCm39) F1127V possibly damaging Het
Wdr25 C T 12: 108,992,393 (GRCm39) Q435* probably null Het
Zc3h7b T G 15: 81,664,719 (GRCm39) L526R probably damaging Het
Zeb1 C A 18: 5,705,127 (GRCm39) T48K possibly damaging Het
Zfhx2 A C 14: 55,303,243 (GRCm39) S1580R probably benign Het
Zfhx3 A G 8: 109,583,549 (GRCm39) I1139V possibly damaging Het
Zfp536 C A 7: 37,179,492 (GRCm39) V1038L probably benign Het
Zfp759 T A 13: 67,286,947 (GRCm39) V166E probably benign Het
Zfp985 A T 4: 147,667,883 (GRCm39) K250N possibly damaging Het
Other mutations in H2-DMa
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL03286:H2-DMa APN 17 34,356,083 (GRCm39) splice site probably null
R0422:H2-DMa UTSW 17 34,356,921 (GRCm39) missense probably damaging 1.00
R0620:H2-DMa UTSW 17 34,356,934 (GRCm39) missense probably damaging 0.96
R1240:H2-DMa UTSW 17 34,357,380 (GRCm39) critical splice acceptor site probably null
R1483:H2-DMa UTSW 17 34,354,724 (GRCm39) missense possibly damaging 0.61
R1656:H2-DMa UTSW 17 34,357,116 (GRCm39) missense possibly damaging 0.92
R1657:H2-DMa UTSW 17 34,356,373 (GRCm39) critical splice donor site probably null
R1696:H2-DMa UTSW 17 34,357,387 (GRCm39) missense probably benign 0.44
R2884:H2-DMa UTSW 17 34,356,121 (GRCm39) missense probably damaging 1.00
R2886:H2-DMa UTSW 17 34,356,121 (GRCm39) missense probably damaging 1.00
R5024:H2-DMa UTSW 17 34,357,461 (GRCm39) missense possibly damaging 0.77
R5236:H2-DMa UTSW 17 34,356,913 (GRCm39) missense probably damaging 1.00
R5632:H2-DMa UTSW 17 34,356,975 (GRCm39) missense probably benign 0.14
R6358:H2-DMa UTSW 17 34,356,958 (GRCm39) missense probably damaging 1.00
R6423:H2-DMa UTSW 17 34,356,170 (GRCm39) missense probably benign 0.05
R7033:H2-DMa UTSW 17 34,355,971 (GRCm39) splice site probably null
R7387:H2-DMa UTSW 17 34,357,101 (GRCm39) missense probably damaging 1.00
R8060:H2-DMa UTSW 17 34,356,259 (GRCm39) missense probably benign 0.05
R8813:H2-DMa UTSW 17 34,354,734 (GRCm39) critical splice donor site probably benign
R9442:H2-DMa UTSW 17 34,357,132 (GRCm39) missense possibly damaging 0.82
Predicted Primers PCR Primer
(F):5'- CGGTCCTTCAAGGGGTGAAAAG -3'
(R):5'- CAAGTGGAGAATCCTGGCAC -3'

Sequencing Primer
(F):5'- GGTGGGGCCCTCTAATTTTAC -3'
(R):5'- TGGAGAATCCTGGCACACACTG -3'
Posted On 2020-10-20